Physician profile
Prem C Kumar
NPI 1700841350
$2,597.76
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $413 · 2021: $1,063 · 2022: $231 · 2024: $42.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $785.74 | 2019-2021 | |
| Abbvie INC. | $429.51 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $386.41 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $216.71 | 2019-2022 | |
| Braintree Laboratories, INC. | $128.09 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $116.46 | 2019 | |
| Qol Medical, LLC | $96.96 | 2019-2021 | |
| Celgene Corporation | $73.04 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $72.02 | 2021 | |
| Allergan, INC. | $69.51 | 2019 | |
| Janssen Biotech, INC. | $36.68 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $29.19 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $25.29 | 2021 | |
| Alfasigma USA, INC. | $23.00 | 2020-2021 | |
| Laborie Medical Technologies Corp. | $22.01 | 2024 | Solar Uroflow System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.83 | 2024 | Nucala |
| Philips North America LLC | $19.17 | 2021 | |
| Qiagen, LLC | $19.12 | 2022 | |
| Intercept Pharmaceuticals, INC. | $16.81 | 2020 | |
| Axonics, INC. | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prem Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.